The prospective, head-to-head trial demonstrated that the company’s Oncoguard® Liver blood test delivers superior early-stage and overall sensitivity for hepatocellular carcinoma (HCC) — the most common form of liver cancer — compared to the current standard of care....
Speaking at WTC Early Stage Symposium in Madison during her third day on the job, Brickerman discussed how her past work with startup accelerator gener8tor will shape her approach to leading the organization....
Innovators from across the state gathered Tuesday at Monona Terrace Community and Convention Center as the Wisconsin Technology Council presented the 2025 Wisconsin Innovation Awards....
Patrick Tetzlaff and Brian Leadingham, run Design Department, Inc., a Franklin-based product development consultancy. The team will present the spherical canister during the Elevator Pitch Olympics, part of the Early Stage Symposium presented by the WTC....
Sahab Aslam, founder of Vectorify Labs and the AI sector lead at the Harvard Business School Alumni Angels of New York, was a featured speaker during yesterday’s WTC luncheon in Madison....
EMP-012’s novel mechanism of action, discovered by Empirico, targets a distinct inflammatory pathway introducing the potential for a therapeutic approach that is agnostic of baseline type 2 inflammation, smoking or co-morbid disease. ...
“Our platforms eliminate lengthy optimization, supporting a seamless path from initial discovery to clinical ADC candidates,” said Bonnie Hammer, Executive VP R&D of Invenra....
Under Tom’s leadership, the Wisconsin Technology Council created the premier statewide conferences aimed at entrepreneurs and investors, the Early Stage Symposium and the Wisconsin Entrepreneur’s Network. These events bring together hundreds of people interested in high growth potential startups each year....
Kauten was an early backer, founder and executive in a handful of Wisconsin biotech sciences, including Promega, PanVera, Mirus Bio, Quintessence Biosciences and Lucigen. He is known for creating companies that reach successful “exits,” meaning they were sold or acquired by larger firms to the...
One MRD test now being used in clinical practice is the Oncodetect™ test±, launched by Exact Sciences in early 2025 and now covered by Medicare....